2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Miricorilant: new trials by email Literature Review of Miricorilant trials Research Report on Miricorilant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo Miricorilant, Placebo oral tablet - Alcohol Use Disorder | Phase 2 | Completed | The Scripps Research Institute | 50 | 2021-04-15 | 2023-02-03 |
| A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications Miricorilant, Placebo - Antipsychotic-induced Weight Gain (AIWG) | Phase 2 | Completed | Corcept Therapeutics | 71 | 2019-12-04 | 2024-09-19 |
Alcohol-Related Disorders (1) · Alcoholism (1) · Bipolar Disorder (1) · Mental Disorders (1) · Obesity (1) · Schizophrenia (1) · Weight Gain (1)
Corcept Therapeutics (1) · The Scripps Research Institute (1)
United States (2)
Barbara J. Mason, Ph.D. (1) · Kavita Juneja, MD (1)
U01AA025476 (1)